SAWAI GROUP HOLDINGS Co.,Ltd.

4887

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-10FY2027 Q1

Revenue

2037.9100M JPY

YoY +4.9%

Operating Income

49.5100M JPY

YoY -29.0%

Net Income

79.8100M JPY

YoY +480.5%

EPS

21.0JPY

YoY -50.3%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2016.8億円

1422.8億円

828.9億円

235億円

-358.9億円

Rev: 1938.2億円Op: -358.9億円NI: -282.7億円

Rev: 2003.4億円Op: 169.8億円NI: 126.7億円

Rev: 1768.6億円Op: 186.2億円NI: 136.9億円

Rev: 1890.2億円Op: 40.5億円NI: 119.7億円

Rev: 2016.8億円Op: 158.9億円NI: 104.4億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income13.1%

Revenue Progress516.200M

Revenue Forecast208400M

Net Income Progress24.300M

Net Income Forecast18600M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan